Ignite Creation Date:
2025-12-24 @ 2:33 PM
Ignite Modification Date:
2026-01-25 @ 1:52 AM
Study NCT ID:
NCT02504359
Status:
COMPLETED
Last Update Posted:
2020-11-23
First Post:
2015-07-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma
Sponsor:
OHSU Knight Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-07-20
Start Date Type:
ACTUAL
Primary Completion Date:
2020-09-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-09-09
Completion Date Type:
ACTUAL
First Submit Date:
2015-07-20
First Submit QC Date:
None
Study First Post Date:
2015-07-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-11-19
Last Update Post Date:
2020-11-23
Last Update Post Date Type:
ACTUAL